Vascular Endothelial Growth Factor Drives Autocrine Epithelial Cell Proliferation and Survival in Chronic Rhinosinusitis with Nasal Polyposis
Authors:
- 1 December 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 180 (11) , 1056-1067
Abstract
Rationale: The pathogenesis of nasal polyps in chronic rhinosinusitis is poorly understood. Objectives: These studies seek to implicate a functional role for vascular endothelial growth factor (VEGF) in perpetuating primary nasal epithelial cell overgrowth, a key feature of hyperplastic polyps. Methods: Comparison of VEGF and receptor expression was assessed by ELISA of nasal lavage, immunohistochemistry of sinus tissue, flow cytometry of nasal epithelial cells, and ELISA of supernatants. VEGF-dependent cell growth and apoptosis were assessed with blocking antibodies to VEGF, their receptors, or small interfering RNA knockdown of neuropilin-1 by cell proliferation assays and flow cytometric binding of annexin V. Measurements and Main Results: VEGF protein was sevenfold higher in nasal lavage from patients with polyposis compared with control subjects (P < 0.001). We also report elevated expression of VEGF (P < 0.012), receptors VEGFR2 and phospho-VEGFR2 (both P < 0.04), and identification of VEGF coreceptor neuropilin-1 in these tissues. Nasal epithelial cells from patients with polyps demonstrated faster growth rates (P < 0.005). Exposure of cells to blocking antibodies against VEGF resulted in inhibition of cell growth (P < 0.05). VEGF receptor blockade required blockade of neuropilin-1 (P < 0.05) and resulted in increased apoptosis (P < 0.001) and inhibition of autocrine epithelial VEGF production (P < 0.05). Conclusions: These data demonstrate that VEGF is a novel biomarker for chronic rhinosinusitis with hyperplastic sinonasal polyposis that functions in an autocrine feed-forward manner to promote nasal epithelial cell growth and to inhibit apoptosis. These findings implicate a previously unrecognized and novel role of VEGF functioning through neuropilin-1 on nonneoplastic primary human airway epithelial cells, to amplify cell growth, contributing to exuberant hyperplastic polyposis.Keywords
Funding Information
- National Institutes of Health (AI57400)
This publication has 72 references indexed in Scilit:
- Role of Platelet-Derived Growth Factor in Airway Remodeling in RhinosinusitisAmerican Journal of Rhinology & Allergy, 2009
- The effect of topical amphotericin B on inflammatory markers in patients with chronic rhinosinusitis: A multicenter randomized controlled studyThe Laryngoscope, 2009
- Induction of B7-H1 and B7-DC expression on airway epithelial cells by the Toll-like receptor 3 agonist double-stranded RNA and human rhinovirus infection: In vivo and in vitro studiesJournal of Allergy and Clinical Immunology, 2008
- Rhinosinusitis: Developing guidance for clinical trialsJournal of Allergy and Clinical Immunology, 2006
- Molecular Profile of the Antrochoanal Polyp: Up-Regulation of Basic Fibroblast Growth Factor and Transforming Growth Factor β in Maxillary Sinus MucosaAmerican Journal of Rhinology, 2006
- Novel Function for Vascular Endothelial Growth Factor Receptor-1 on Epidermal KeratinocytesThe American Journal of Pathology, 2005
- Airway Remodeling in Asthma: Therapeutic Implications of MechanismsPhysiology, 2005
- Vascular endothelial growth factor in nasal polyps: a comparison of asthmatic and non-asthmatic patientsClinical Otolaryngology, 2004
- Vascular endothelial growth factor mRNA and protein expression in airway epithelial cell linesin vitroEuropean Respiratory Journal, 2002
- The Clinical Relationship of Nasal Polyps to AsthmaAllergy and Asthma Proceedings, 1996